This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of complex organic molecules. Its structure is particularly valuable in the development of drugs targeting neurological disorders, where the bicyclic framework and functional groups enhance binding affinity and selectivity. It is also employed in the preparation of peptidomimetics, which mimic peptides and are used to create more stable and bioavailable therapeutic agents. Additionally, its fluorine atom makes it a useful building block in the design of radiopharmaceuticals for imaging and diagnostic purposes. The tert-butoxycarbonyl (Boc) protecting group allows for controlled deprotection during synthetic processes, ensuring precision in drug development.